Skip to main content
Loading

Considerations and challenges guiding target selection in the development of antibody-based therapeutics for cancer (TOPIC TBC)

23 Sep 2024
Target Selection
Industry Expert
Steven Everett, Founder & CEO - MaveriX Oncology, Inc.